The 5-year survival probability HRs suggested that TNBC patients have a 2-fold increased risk of death if their tumours display increased expression of phospho-BAD-Ser136 (AKT phosphorylation site) or phospho-BAD-Ser155 (PKA phosphorylation site). This evidence concerns the gene AKT1 and neoplasm.